Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7150
+0.0450 (2.69%)
NASDAQ· Last Trade: Jun 4th, 11:44 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors